by Bo Koppert | Oct 6, 2025 | News
A month after being cleared to sell its animal-free meat fat in the US, Nourish Ingredients has set its sights on the global market with a new commercial hub in the Netherlands. Set to be fully operational by 2026, the facility is located at Leiden’s BioPartner 5, a...
by Bas Oudshoorn | Oct 2, 2025 | News
Dutch biotech Leyden Labs has raised a €30 million equity investment from the European Innovation Council (EIC) Fund and Invest-NL to accelerate the development of its PanFlu nasal spray, as well as the Company’s other mucosal pipeline and platform activities. The...
by Bo Koppert | Sep 30, 2025 | News
Leiden, 26 September 2025. For the first time, LUMC has used a surgical robot to remove a piece of liver from a living donor and successfully transplant it into a patient. A woman received part of her cousin’s healthy liver. Both the donor and the recipient are doing...
by Bilyana LBSP | Sep 26, 2025 | News
Rapidemic, located at BioPartner 3, within the Leiden Bio Science Park, has secured $2.7 million in funding from the Bill & Melinda Gates Foundation to accelerate the development of RapiDetect CT/NG, a rapid diagnostic test for Chlamydia trachomatis and Neisseria...
by Bo Koppert | Sep 26, 2025 | News
We’ve reached a milestone worth celebrating: the official opening of our expanded AMS laboratory. Surrounded by clients, partners, colleagues and key organizations, we marked this moment with pride and dedication. A special thank you to Mayor Peter Heijkoop of Leiden...
by Bo Koppert | Sep 26, 2025 | News
The Japanese regulator, the PMDA, waived the requirement for a Phase 1 trial in Japanese subjects for lead asset VMX-C001, enabling it to go straight to Phase 3 development. This rare waiver recognizes the global dataset already generated for VMX-C001 and streamlines...